Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.69 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.63 |
| ▸ | MAOA | P21397 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | CHAT | P28329 | 2/20 | 0.57 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 2/20 | 0.55 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.55 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | TNKS | O95271 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (Z)-1,2-Diphenylethene SCHEMBL1282295 | 1.00 | MAOB (0.69) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL27480001 | 1.00 | MAOB (0.69) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL1376696 | 1.00 | MAOB (0.69) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL28186405 | 0.96 | MAOB (0.65) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL347707 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL21847984 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL443 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL22712863 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL9134305 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL9488275 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111138415-A | Application of bifunctional chelating agent in uranium excretion promotion and radiation protection | 中国人民解放军第四军医大学 | 2020-05-12 | — | — | CN | claimed |
| US-20100179323-A1 | PROCESS FOR MAKING DIPHOSPINE-RUTHENIUM-DIAMINE COMPLEXES | DR. REDDY'S LABORATORIES LIMITED (IN) | 2010-07-15 | — | — | US | claimed |
| EP-1902061-B1 | PROCESS FOR MAKING DIPHOSPHINE-RUTHENIUM-DIAMINE COMPLEXES | REDDY S LAB EU LTD DR (GB) | 2009-12-30 | — | — | EP | claimed |
| EP-1902061-A1 | PROCESS FOR MAKING DIPHOSPHINE-RUTHENIUM-DIAMINE COMPLEXES | Dow Gloval Technologies Inc. (US) | 2008-03-26 | — | — | EP | claimed |
| WO-2007005550-A1 | PROCESS FOR MAKING DIPHOSPHINE-RUTHENIUM-DIAMINE COMPLEXES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2007-01-11 | — | — | WO | claimed |
| US-5763688-A | HYDROGENATING A CARBONYL COMPOUND, RUTHENIUM-PHOSPHINE COMPLEX CATALYST, BASE, DIAMINE | RESEARCH DEVELOPMENT CORPORATION OF JAPAN (JP) | 1998-06-09 | — | — | US | claimed |
| US-4705757-A | Method for fluorometric analysis of catechol amines | TOYO SODA MANUFACTURING CO., LTD. (JP) | 1987-11-10 | — | — | US | claimed |
| JP-56084881-A | — | — | None | — | — | JP | disclosed |
| JP-6058930-A | — | — | None | — | — | JP | disclosed |
| JP-56084880-A | — | — | None | — | — | JP | disclosed |
| CN-116425753-A | Pyrrolizine skeleton pyrimidine ring substituted derivative, preparation method thereof and flow battery | 西安交通大学 | 2023-07-14 | — | — | CN | disclosed |
| CN-116368168-A | Novel antimicrobial and antithrombotic medical device | 列日大学 | 2023-06-30 | — | — | CN | disclosed |
| CN-114736240-A | Phosphorus prodrugs of sGC stimulators | 赛克里翁治疗有限公司 | 2022-07-12 | — | — | CN | disclosed |
| US-5210210-A | CHIRAL AUXILIARIES AND THEIR USE IN THE SYNTHESIS OF CHIRAL MOLECULES | THE BRITISH PETROLEUM COMPANY P.L.C. (GB) | 1993-05-11 | — | — | US | disclosed |
| WO-1993003838-A1 | CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-03-04 | — | — | WO | disclosed |
| EP-0521099-A1 | CHIRAL CATALYSTS AND EPOXIDATION REACTIONS CATALYZED THEREBY | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-01-07 | — | — | EP | disclosed |
| EP-0457469-A1 | Chiral auxiliaries and their use in the synthesis of chiral molecules | THE BRITISH PETROLEUM COMPANY P.L.C. (GB) | 1991-11-21 | — | — | EP | disclosed |
| WO-1991014694-A1 | CHIRAL CATALYSTS AND EPOXIDATION REACTIONS CATALYZED THEREBY | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-10-03 | — | — | WO | disclosed |
| JP-S5684880-A | BATTERY WITH NONAQUEOUS ELECTROLYTE | HITACHI MAXELL LTD | 1981-07-10 | — | — | JP | disclosed |
| JP-S5684881-A | BATTERY WITH NONAQUEOUS ELECTROLYTE | HITACHI MAXELL LTD | 1981-07-10 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179323-A1 | PROCESS FOR MAKING DIPHOSPINE-RUTHENIUM-DIAMINE COMPLEXES | DPY30, POP1, PPIP5K2 | MAOB 4049/4885NFE2L2 2698/4885CYP19A1 3503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.